0
Clinical-stage biotech company Eyestem Research recently secured $10 million in a Series B round led by Prabhavati Agro Green Energies with the participation of Jacesa Investments, BNS Capital, Alkem Labs, among others.
The Bengaluru-based company did not disclose key details such as its post-money valuation and shareholding structure in its announcement. Entrackr has sifted through the regulatory filings to uncover the critical details.
The board at Eyestem has issued 45,502 Series B compulsory convertible preference shares at an issue price of Rs…
